Get the Stockscreener App
17.52
2.57%
0.38
Staar Surgical Co stock is traded at $17.52, with a volume of 123.15K.
It is up +2.57% in the last 24 hours and down -3.25% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$17.14
Open:
$17.19
24h Volume:
123.15K
Relative Volume:
0.14
Market Cap:
$899.89M
Revenue:
$341.22M
Net Income/Loss:
$21.78M
P/E Ratio:
39.82
EPS:
0.44
Net Cash Flow:
$26.30M
1W Performance:
-1.57%
1M Performance:
-3.25%
6M Performance:
-23.57%
1Y Performance:
-61.78%
1-Day Range:
$17.16
$17.59
1-Week Range:
$16.52
$17.68
52-Week Range:
$13.50
$49.86
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
17.52 | 899.89M | 341.22M | 21.78M | 26.30M | 0.44 |
|
ISRG
Intuitive Surgical Inc
|
524.02 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.18 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.52 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
259.40 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
230.03 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
Staar Surgical Holds Annual Shareholders Meeting - TipRanks
Piper Sandler maintains neutral rating on STAAR Surgical stock amid China woes By Investing.com - Investing.com South Africa
Piper Sandler maintains neutral rating on STAAR Surgical stock amid China woes - Investing.com India
Midday Stock Roundup: Xponential Fitness Down, Yoshiharu Up - Orange County Business Journal
Bright Future: Cataract Surgery Devices Market Soars to $12.2B by 2030 with Innovation - newstrail.com
Staar Surgical Co (STAA) Shares Gap Down to $17.535 on Jun 11 - GuruFocus
STAA Q1 Earnings Call: Tariff Mitigation, Cost Cuts, and China Inventory Reshape Outlook - Yahoo Finance
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 13,075 Shares of STAAR Surgical (NASDAQ:STAA) - Defense World
Intraocular Lens Market Emerging Tech Trends to Watch from 2025 to 2032 - newstrail.com
STAAR Surgical at William Blair Conference: Strategic Shifts Amid Challenges By Investing.com - Investing.com South Africa
STAAR Surgical at William Blair Conference: Strategic Shifts Amid Challenges - Investing.com Australia
Staar Surgical Co (STAA) Trading Down 5.84% on Jun 2 - GuruFocus
Staar Surgical Co (STAA) Trading Down 3.22% on May 30 - GuruFocus
Phakic Intraocular Lens Manufacturing 2025: Market Surge & Innovation Unveiled - macholevante.com
Staar Surgical Co (STAA) Stock Price Down 4.12% on May 28 - GuruFocus
Why LASIK Isn't for Everyone: Houston Lasik & Eye Introduces EVO ICL as a Personalized Solution - USA Today
Canaccord Genuity Maintains Hold Rating for STAA with $20 Price Target | STAA Stock News - GuruFocus
STAAR Surgical (NASDAQ:STAA) Receives Hold Rating from Canaccord Genuity Group - Defense World
STAAR Surgical at Stifel Forum: Strategic Moves and Market Challenges - Investing.com Australia
STAAR Surgical at Stifel Forum: Strategic Moves and Market Challenges By Investing.com - Investing.com India
Staar Surgical Q1 Sales Drop 45% on Weak China Demand - Orange County Business Journal
Deutsche Bank AG Has $1.10 Million Stake in STAAR Surgical (NASDAQ:STAA) - Defense World
Ameriprise Financial Inc. Raises Position in STAAR Surgical (NASDAQ:STAA) - Defense World
STAAR Surgical Announces Participation in Upcoming Investor Conferences - Business Wire
Fortune Brands, Whirlpool, Align Technology, Tandem Diabetes, and STAAR Surgical Shares Plummet, What You Need To Know - Yahoo Finance
Staar Surgical (STAA) Receives 'Hold' Rating Reiteration from Ne - GuruFocus
STAAR Surgical stock target raised at Jefferies to $21 By Investing.com - Investing.com South Africa
STAAR Surgical stock target raised at Jefferies to $21 - Investing.com Australia
STAAR Surgical (NASDAQ:STAA) Shares Bought by BNP Paribas Financial Markets - Defense World
STAAR Surgical Company look to conduct $30M share buyback program - MSN
Staar Surgical Co (STAA) Getting Ready To Launch, Waiting For The Long Term Buyers - Stocksregister
Northern Trust Corp Reduces Stock Holdings in STAAR Surgical (NASDAQ:STAA) - Defense World
STAAR Surgical authorizes $30 million stock buyback By Investing.com - Investing.com South Africa
STAAR Surgical authorizes $30 million stock buyback - Investing.com Australia
Staar Surgical Announces $30 Million Share Repurchase Authorization - marketscreener.com
Staar Surgical (STAA) Board Approves $30 Million Share Buyback | - GuruFocus
STAAR Surgical Announces Major Stock Buyback: $30M Program Signals Management Confidence - Stock Titan
How Implantable Collamer Lenses Market: Improve Vision Clarity By 2031 - openPR.com
Global Intraocular Lens Market to Witness Upsurge in Growth at a CAGR of ~5% by 2032 | DelveInsight - GlobeNewswire
STAAR Surgical (NASDAQ:STAA) Position Reduced by Tower Research Capital LLC TRC - Defense World
The STAAR Surgical Company (NASDAQ:STAA) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo
Staar Surgical (STAA) Price Target Raised by Canaccord Genuity | - GuruFocus
Quarterly Snapshot: Quick and Current Ratios for Staar Surgical Co (STAA) - DWinneX
STAAR Surgical Company (NASDAQ:STAA) Q1 2025 Earnings Call Transcript - Insider Monkey
STAAR Surgical’s Earnings Call: Growth Amid Challenges - TipRanks
Staar Surgical Withdraws FY 2025 Guidance Amid Tariffs & Economic Uncertainty - Medical Device and Diagnostic industry
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Staar Surgical Co Stock (STAA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 09 '25 |
Buy |
15.08 |
8,200 |
123,676 |
13,518,591 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 10 '25 |
Buy |
15.18 |
900 |
13,658 |
13,519,491 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 04 '25 |
Buy |
15.91 |
497,631 |
7,917,191 |
13,194,210 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 03 '25 |
Buy |
16.97 |
209,535 |
3,555,138 |
12,696,579 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 07 '25 |
Buy |
15.61 |
138,054 |
2,155,174 |
13,332,264 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 02 '25 |
Buy |
17.43 |
31,780 |
553,925 |
12,487,044 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 31 '25 |
Buy |
17.46 |
22,189 |
387,360 |
12,455,264 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 26 '25 |
Buy |
17.50 |
101,633 |
1,778,517 |
12,421,324 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 28 '25 |
Buy |
17.47 |
8,131 |
142,014 |
12,433,075 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 27 '25 |
Buy |
17.48 |
3,620 |
63,294 |
12,424,944 |
1.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):